enow.com Web Search

  1. Ad

    related to: causes of mosaic lung attenuation definition treatment for cancer mayo clinic

Search results

  1. Results from the WOW.Com Content Network
  2. Ground-glass opacity - Wikipedia

    en.wikipedia.org/wiki/Ground-glass_opacity

    Sarcoidosis is an additional cause of a mosaic GGOs due to the formation of granulomas in interstitial areas. This may coexist with granulomatosis with polyangiitis, leading to diffuse areas of increased attenuation with ground-glass appearance. [6]

  3. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

    en.wikipedia.org/wiki/Diffuse_idiopathic...

    Pulmonary function: increased residual volume, increased total lung capacity, fixed obstruction, low diffusing capacity of the lung for carbon monoxide that corrects with alveolar volume; High-resolution CT scan: diffuse pulmonary nodules 4–10 mm, greater than 20 nodules, mosaic attenuation or air trapping in greater than 50% of the lung

  4. Bronchiolitis obliterans - Wikipedia

    en.wikipedia.org/wiki/Bronchiolitis_obliterans

    Bronchiolitis obliterans results in worsening shortness of breath, wheezing, and a dry cough.The symptoms can start gradually, or severe symptoms can occur suddenly. [9] [10] These symptoms represent an obstructive pattern that is non-reversible with bronchodilator therapy, and need to be related to various lung insults. [11]

  5. Usual interstitial pneumonia - Wikipedia

    en.wikipedia.org/wiki/Usual_interstitial_pneumonia

    The differential diagnosis includes other types of lung disease that cause similar symptoms and show similar abnormalities on chest radiographs. Some of these diseases cause fibrosis, scarring or honeycomb change. The most common considerations include: chronic hypersensitivity pneumonitis; non-specific interstitial pneumonia; sarcoidosis

  6. Adenocarcinoma in situ of the lung - Wikipedia

    en.wikipedia.org/wiki/Adenocarcinoma_in_situ_of...

    The incidence of bronchiolo-alveolar carcinoma has been reported to vary from 4–24% of all lung cancer patients. [23] An analysis of Surveillance epidemiology and End results registry ( SEER) by Read et al. revealed that although the incidence of BAC has increased over the past two decade it still constitutes less than 4% of NSCLC in every ...

  7. Interstitial lung disease - Wikipedia

    en.wikipedia.org/wiki/Interstitial_lung_disease

    Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD), [3] is a group of respiratory diseases affecting the interstitium (the tissue) and space around the alveoli (air sacs) of the lungs. [4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. It ...

  8. Pancoast tumor - Wikipedia

    en.wikipedia.org/wiki/Pancoast_tumor

    The Pancoast tumor was first described by Hare in 1838 as a "tumor involving certain nerves". [2] It was not until 1924 that the tumor was described in further detail, when Henry Pancoast, a radiologist from Philadelphia, published an article in which he reported and studied many cases of apical chest tumors that all shared the same radiographic findings and associated clinical symptoms, such ...

  9. Diffuse alveolar damage - Wikipedia

    en.wikipedia.org/wiki/Diffuse_alveolar_damage

    Diffuse alveolar damage (DAD) is a histologic term used to describe specific changes that occur to the structure of the lungs during injury or disease.Most often DAD is described in association with the early stages of acute respiratory distress syndrome (). [1]

  1. Ad

    related to: causes of mosaic lung attenuation definition treatment for cancer mayo clinic